Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2020-02-04
1:03 pm
Sale
13GEvofem Biosciences, Inc.
EVFM
Woodford Investment Management Ltd0
0%
-3,913,274decrease
(Position Closed)
View
2020-02-04
1:01 pm
Sale
13GNightstar Therapeutics plc
NITE
Woodford Investment Management Ltd0
0%
-1,921,315decrease
(Position Closed)
View
2019-11-08
3:01 pm
Sale
13GTheravance Biopharma, Inc.
TBPH
Woodford Investment Management Ltd429,770
0.76%
-11,886,759decrease
(-96.51%)
View
2019-11-08
2:58 pm
Sale
13GEvofem Biosciences, Inc.
EVFM
Woodford Investment Management Ltd3,913,274
8.3%
-8,582,948decrease
(-68.68%)
View
2019-10-09
12:28 pm
Sale
13GAutolus Therapeutics plc
AUTL
Woodford Investment Management Ltd2,095,127
4.7%
-8,518,751decrease
(-80.26%)
View
2019-09-09
4:33 pm
Sale
13GProthena Corporation plc
PRTA
Woodford Investment Management Ltd0
0%
-8,773,790decrease
(Position Closed)
View
2019-09-09
4:23 pm
Sale
13GNuCana plc
NCNA
Woodford Investment Management Ltd1,538,000
4.8%
-1,692,999decrease
(-52.40%)
View
2019-08-08
3:13 pm
Sale
13GEvofem Biosciences, Inc.
EVFM
Woodford Investment Management Ltd12,496,222
26.8%
-497,770decrease
(-3.83%)
View
2019-08-08
3:10 pm
Sale
13GAutolus Therapeutics plc
AUTL
Woodford Investment Management Ltd10,613,878
23.6%
-1,311,541decrease
(-11.00%)
View
2019-07-09
2:59 pm
Sale
13GProthena Corporation plc
PRTA
Woodford Investment Management Ltd8,773,790
22%
-3,150,824decrease
(-26.42%)
View
2019-05-10
11:52 am
Purchase
13GEvofem Biosciences, Inc.
EVFM
Woodford Investment Management Ltd12,993,992
35.3%
975,264increase
(+8.11%)
View
2019-04-15
11:47 am
Purchase
13GNuCana plc
NCNA
Woodford Investment Management Ltd3,230,999
10%
1,365,999increase
(+73.24%)
View
2019-02-14
3:48 pm
Purchase
13GNuCana plc
NCNA
Woodford Investment Management Ltd1,865,000
5.8%
1,865,000increase
(New Position)
View
2019-02-14
3:45 pm
Purchase
13GNightstar Therapeutics plc
NITE
Woodford Investment Management Ltd1,921,315
5.8%
1,921,315increase
(New Position)
View
2019-02-14
3:37 pm
Purchase
13GProthena Corporation plc
PRTA
Woodford Investment Management Ltd11,924,614
29.9%
396,000increase
(+3.43%)
View
2019-02-14
3:34 pm
Purchase
13GTheravance Biopharma, Inc.
TBPH
Woodford Investment Management Ltd12,316,529
22.2%
1,569,421increase
(+14.60%)
View
2019-02-14
3:18 pm
Unchanged
13GNorthwest Biotherapeutics, Inc.
NWBO
Woodford Investment Management Ltd24,815,028
4.8%
0
(Unchanged)
View
2019-01-10
12:11 pm
Purchase
13GAutolus Therapeutics plc
AUTL
Woodford Investment Management Ltd11,925,419
29.7%
2,261,417increase
(+23.40%)
View
2018-12-10
2:40 pm
Purchase
13GEvofem Biosciences, Inc.
EVFM
Woodford Investment Management Ltd12,018,728
42.5%
1,999,999increase
(+19.96%)
View